Document is current
Any future updates will be listed below
-
Authors
Feng, Lijun
Zhang, Yuxuan
Zhang, Chenyun
Chen, Zining
Pan, Jingnan
Gao, Zhiling
Chen, Delong
Yidilisi, Abuduwufuer
Fang, Jiacheng
Zheng, Yiyue
Mei, Tingting
Liu, Jiantao
Xiang, Jianping
Zhang, Jinlong
Li, Changling
Cheng, Jifang
Wang, Jian’an
jiang, Jun
Wang, Jian’an
-
Funding
Funding for this research was provided by:
General scientific research project of the Zhejiang Education Department (Y202249433)
Zhejiang Provincial Key Research and Development Plan (2024C03095)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0504100)
National Natural Science Foundation of China (82170332)
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 15 July 2025
First Online: 24 July 2025
Declarations
:
: Our study was approved by the local Human Research Ethics Committee and conducted in accordance with the Helsinki Declaration. Given the retrospective design of the study, which utilized anonymized data, the committee exempted the requirement for individual participant consent. Furthermore, the study has been registered on ClinicalTrials.gov (NCT06702748).
: Not applicable.
: Dr. Jianping Xiang is principal scientist of ArteryFlow Technology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
